Jorge Jalil

5.1k total citations · 1 hit paper
110 papers, 4.0k citations indexed

About

Jorge Jalil is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Jorge Jalil has authored 110 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Cardiology and Cardiovascular Medicine, 32 papers in Endocrinology, Diabetes and Metabolism and 31 papers in Molecular Biology. Recurrent topics in Jorge Jalil's work include Hormonal Regulation and Hypertension (27 papers), Renin-Angiotensin System Studies (25 papers) and Cardiovascular Function and Risk Factors (15 papers). Jorge Jalil is often cited by papers focused on Hormonal Regulation and Hypertension (27 papers), Renin-Angiotensin System Studies (25 papers) and Cardiovascular Function and Risk Factors (15 papers). Jorge Jalil collaborates with scholars based in Chile, United States and Colombia. Jorge Jalil's co-authors include María Paz Ocaranza, Joseph S. Janicki, K. T. Weber, R Pick, Sergio Lavandero, Mario Chiong, Lip Bun Tan, Lorena Garcı́a, Sanjeev G. Shroff and Jaime A. Riquelme and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Jorge Jalil

104 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Counter-regulatory renin–angiotensin system in cardiovascular disease

2019 398 citations María Paz Ocaranza, Jaime A. Riquelme et al. profile →

Peers

Countries citing papers authored by Jorge Jalil

Since Specialization

Citations

This map shows the geographic impact of Jorge Jalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Jalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Jalil more than expected).

Fields of papers citing papers by Jorge Jalil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Jalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Jalil. The network helps show where Jorge Jalil may publish in the future.

Co-authorship network of co-authors of Jorge Jalil

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Jalil. A scholar is included among the top collaborators of Jorge Jalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Jalil. Jorge Jalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review 2024 ·International Journal of Molecular Sciences ·Jorge Jalil, Luigi Gabrielli, María Paz Ocaranza, (unknown), Rodrigo Fernández, (unknown), (unknown), Hugo Verdejo, Mónica Acevedo, Samuel Córdova, (unknown), Douglas Greig	11
2	Reverse Remodeling in Human Heart Failure after Cardiac Resynchronization Therapy Is Associated With Reduced RHO-Kinase Activation 2021 ·Frontiers in Pharmacology ·María Paz Ocaranza, Jorge Jalil, (unknown), (unknown), (unknown), (unknown), Luigi Gabrielli, (unknown), Samuel Córdova, (unknown), Ismael A. Vergara, Alex Bittner, (unknown), (unknown)	3
3	Antihipertensivos en pacientes con COVID-19 2020 ·Revista chilena de cardiología ·(unknown), (unknown), María Paz Ocaranza, Mario Chiong, Jaime A. Riquelme, Jorge Jalil, Sergio Lavandero	2
4	Angiotensin-(1–9) prevents vascular remodeling by decreasing vascular smooth muscle cell dedifferentiation through a FoxO1-dependent mechanism 2020 ·Biochemical Pharmacology ·Ignacio Norambuena‐Soto, María Paz Ocaranza, (unknown), Fernanda Sanhueza‐Olivares, (unknown), (unknown), (unknown), (unknown), Ulises Novoa, Jorge Jalil, Pablo Castro, Sergio Lavandero, Mario Chiong	13
5	Biomarcadores de fibrosis y función ventricular derecha en maratonistas con distinto grado de entrenamiento: estudio en la Maratón de Santiago 2019 ·Revista chilena de cardiología ·(unknown), María Paz Ocaranza, (unknown), (unknown), Manuel Salinas, (unknown), (unknown), Jorge Jalil, Fernando Yáñez, (unknown), Samuel Córdova, Mario Chiong, (unknown), Sergio Lavandero, Pablo Castro, Luigi Gabrielli	1
6	Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1–9) through an AT2R and Akt-dependent mechanism 2018 ·Pharmacological Research ·Evelyn Mendoza‐Torres, Jaime A. Riquelme, (unknown), (unknown), Luigi Gabrielli, Roberto Bravo, Jorge Jalil, Beverly A. Rothermel, Gina Sánchez, María Paz Ocaranza, Sergio Lavandero	27
7	Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension 2018 ·Biochemical Pharmacology ·Leticia González, Ulises Novoa, (unknown), Luigi Gabrielli, Jorge Jalil, Lorena Garcı́a, Mario Chiong, Sergio Lavandero, María Paz Ocaranza	36
8	Does Good Aerobic Capacity Attenuate the Effects of Aging on Cardiovascular Risk Factors? Results from a Cross-Sectional Study in a Latino Population 2017 ·International Journal of Endocrinology ·(unknown), Mónica Acevedo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jorge Jalil, Carlos Navarrete	3
9	Gaps and Resemblances in Current Heart Failure Guidelines 2015 ·Heart Failure Clinics ·(unknown), Jorge Jalil	1
10	Effects of Trimetazidine in Nonischemic Heart Failure: A Randomized Study 2014 ·Journal of Cardiac Failure ·(unknown), Pablo Castro, Juan Carlos Quintana, (unknown), (unknown), Hugo Verdejo, Jorge Jalil, Rosemarie Mellado, (unknown), Pablo Sepúlveda, (unknown), (unknown), Mario Chiong, Lorena Garcı́a, Sergio Lavandero	19
11	Increased Rho-Kinase Activity in Hypertensive Patients With Left Ventricular Hypertrophy 2013 ·American Journal of Hypertension ·Luigi Gabrielli, (unknown), Iván Godoy, (unknown), (unknown), Samuel Córdova, Paolo Rigotti, Ulises Novoa, (unknown), Lorena Garcı́a, María Paz Ocaranza, Jorge Jalil	32
12	RHO-KINASE ACTIVITY IS INCREASED IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY. 2010 ·Journal of the American College of Cardiology ·Luigi Gabrielli, Jorge Jalil, Iván Godoy, (unknown), (unknown), Samuel Córdova, (unknown), Ulises Novoa, (unknown), Sergio Lavandero, Lorena García, María Paz Ocaranza	0
13	Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients 2010 ·Journal of Hypertension ·(unknown), Rosemarie Mellado, María Paz Ocaranza, Cristián A. Carvajal, Lorena Mosso, (unknown), (unknown), (unknown), Sergio Lavandero, Jorge Jalil, Carlos Fardella	65
14	Osmotically-induced genes are controlled by the transcription factor TonEBP in cultured cardiomyocytes 2008 ·Biochemical and Biophysical Research Communications ·(unknown), Mario Chiong, (unknown), Francisco Moraga, María Paz Ocaranza, Jorge Jalil, Sun Woo Lim, Jeong‐Ah Kim, Hyug Moo Kwon, Sergio Lavandero	12
15	Effect of hypertension on angiotensin-(1–7) levels in rats with different angiotensin-I converting enzyme polymorphism 2005 ·Life Sciences ·María Paz Ocaranza, (unknown), (unknown), (unknown), Sergio Lavandero, Jorge Jalil	11
16	Neutral endopeptidase and angiotensin I converting enzyme insertion/deletion gene polymorphism in humans 2004 ·Journal of Human Hypertension ·Jorge Jalil, María Paz Ocaranza, (unknown), Samuel Córdova, Iván Godoy, G Chamorro, Sandra Braun, Carlos Fardella, (unknown), Sergio Lavandero	17
17	Levels of plasma angiotensin-(1-7) in patients with hypertension who have the angiotensin–I-converting enzyme deletion/deletion genotype 2003 ·The American Journal of Cardiology ·Jorge Jalil, (unknown), María Paz Ocaranza, Iván Godoy, (unknown), Mario Chiong, Sergio Lavandero	23
18	Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis 1990 ·Cardiovascular Research ·Marc A. Silver, R Pick, Christian G. Brilla, Jorge Jalil, Joseph S. Janicki, K. T. Weber	101
19	Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure 1990 ·The American Journal of Cardiology ·Ramón Corbalán, Jorge Jalil, (unknown), P Casanegra, (unknown)	14
20	Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle 1988 ·Journal of Molecular and Cellular Cardiology ·Jorge Jalil	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact